Candel Therapeutics (CADL) EBT Margin (2020 - 2022)
Candel Therapeutics' (CADL) quarterly EBT Margin came in at 25403.23% in Q4 2022, up 10378011.0% year-on-year from N/an in Q4 2021, and up 13.05% quarter-over-quarter from 29216.13% in Q3 2022.
Candel Therapeutics (CADL) EBT Margin (2020 - 2022) Analysis & Trends
Candel Therapeutics has disclosed EBT Margin across 3 years of filings, most recently posting 25403.23% for Q4 2022.
- EBT Margin for Q4 2022 came in at 25403.23%, up 10378011.0% year-over-year; the trailing twelve-month figure through Dec 2022 was 28395.97% (down 235657.0% YoY), and the FY2022 annual result was 28169.6%, down 239060.0% from the prior year.
- EBT Margin came in at 25403.23% for Q4 2022 at Candel Therapeutics, up from 29216.13% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 8145.16% in Q2 2020 to a low of 129183.33% in Q4 2021.
- The 3-year median for EBT Margin is 25403.23% (2022), against an average of 30672.97%.
- Across the five-year window, EBT Margin slumped 10958333 bps in 2021 and jumped 10378011 bps in 2022, its largest moves.
- Candel Therapeutics' EBT Margin stood at 19600.0% in 2020, then slumped by 559 bps to 129183.33% in 2021, then jumped by 80 bps to 25403.23% in 2022.
- The last three EBT Margin figures came in at 25403.23% (Q4 2022), 29216.13% (Q3 2022), and 29412.9% (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Candel Therapeutics | 440.62 Mn | 440.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -25,403.23% |
| Sep 30, 2022 | -29,216.13% |
| Jun 30, 2022 | -29,412.90% |
| Mar 31, 2022 | -29,551.61% |
| Dec 31, 2021 | -129,183.33% |
| Sep 30, 2021 | -25,945.16% |
| Jun 30, 2021 | -17,148.39% |
| Mar 31, 2021 | -15,061.29% |
| Dec 31, 2020 | -19,600.00% |
| Sep 30, 2020 | -8,735.48% |
| Jun 30, 2020 | -8,145.16% |